| Ytd | 14.69% | |
| 1y | 8.51% |
| Open | 178.20 | Prev Close | 178.44 | Low | 174.83 | High | 178.27 | Mkt Cap | 5.61B |
| Vol | 198.24K | Avg Vol | 221.85K | EPS | 5.09 | P/E | 34.56 | Forward P/E | 28.04 |
| Beta | 0.81 | Short Ratio | 3.19 | Inst. Own | 93.85% | Dividend | 0.96 | Div Yield | 0.54 |
| Ex Div Date | 12-23 | Earning | 10-20 | 50-d Avg | 170.54 | 200-d Avg | 166.34 | 1yr Est | 209.25 |
Top Wall Street analysts changed their outlook on top names. Barclays raised DAR's target to $65
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassin
Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by c
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.49 per share which beat the analyst consensu
MONTVALE, N.J., July 31, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported
MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced
MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global speci
MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specia
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.33 per share which met the analyst consensus
MONTVALE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today
Sherwin-Williams (SHW) came out with quarterly earnings of $2.35 per share, beating the Zacks Consen
The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russ
MONTVALE, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today publishe
Balchem delivered strong Q4 results, with revenue up nearly 10% year-over-year and all segments post
Balchem Plant Nutrition, a global leader in chelated mineral plant nutrition and the maker of Metalo
MONTVALE, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Balchem Plant Nutrition, a global leader in chela
Harvey Partners bought 116,000 shares in Balchem Corporation during the fourth quarter. The quarter-
MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global speci
MONTVALE, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global speci
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem Corporation (BCPC) Q4 2025 Earnings Call Transcript
Stock News Oil climbs on Iran risk: Crude headed for its first weekly gain in three weeks as tension
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.31 per share which beat the analyst consensu
MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today
Rothschild & Co analyst Artem Chubarov initiates coverage on Balchem (NASDAQ:BCPC) with a Neu
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.35 per share which beat the analyst consensu
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.27 per share which beat the analyst consensu
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.22 per share which met the analyst consensus
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Balchem (NASDAQ:BCPC) with a Buy an
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.13 per share which beat the analyst consensu
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.13 per share which beat the analyst consensu